BioWorld Science

May 2, 2005

View Archived Issues

DA-8159 as a treatment for diabetic erectile dysfunction

Read More

CC-4047's mechanism of action remains unclear

Read More

NexBio presents Fludase, a novel antiinfluenza recombinant fusion protein / News in Context

Read More

Two liposomal lurtotecan regimens induce antitumor effects in relapsed ovarian cancer

Read More

CEP-8983 chemosensitizes resistant cells and xenografts

Read More

BTS-2 inhibitory activity depends on redox state of tNOX

Read More

APF-530 enters phase II for CINV in cancer patients

Read More

ISTA seeks green light for phase III trial of combination ophthalmic product

Read More

ZLB Behring to study C1-INH concentrate for hereditary angioedema

Read More

Inspire reports ophthalmic programs update

Read More

Mitsubishi Chemical and Mitsubishi Pharma to form joint holding company

Read More

Phase I cancer study of CYT-997 set to begin in May

Read More

Prism to market Penwest's PW-2101 in U.S., Canada

Read More

Vical's bivalent CMV vaccine set for phase II

Read More

ISIS-369645 enters development for asthma

Read More

New treatments for cancer covered in recent patents

Read More

AS-1410 selected for phase I evaluation against cancer

Read More

Complete tumor regression in mice treated with huC242-DM4

Read More

First, highly selective 5-HT1D antagonist reported

Read More

Novel antihypertensive agents discovered at Bristol-Myers Squibb

Read More

Santarus reports new formulations of omeprazole for treating acid-induced gastrointestinal disorders

Read More

New antidiabetic agents from Ligand and Takeda

Read More

Phase I data confirm MVA-3000 vaccine is safe and immunogenic in healthy volunteers

Read More

Evidence suggests a link between sleep disorders and metabolic syndrome in mice

Read More

UNBS-1450 demonstrates in vitro and in vivo anticancer activity

Read More